Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth
- PMID: 20384751
- DOI: 10.1111/j.1524-4725.2010.01519.x
Safety, effectiveness, and subjective experience with topical bimatoprost 0.03% for eyelash growth
Abstract
Background: Ocularly applied bimatoprost 0.03% is associated with increased eyelash growth.
Objective: To assess the safety, efficacy, and subjective experience of using dermal application of bimatoprost 0.03% for the growth of natural eyelashes.
Methods: Prospective, open-label study of subjects who desired longer, thicker (fuller), and darker natural eyelashes. Bimatoprost was applied to the upper lid margin once daily for 12 weeks. Adverse events and intraocular pressure were assessed, and subjects completed health outcomes questionnaires. Eyelash growth and darkening were scored using photographs taken at weeks 1 and 12.
Results: All subjects were female (N=28). No serious or unexpected adverse events were reported. The mean change from baseline intraocular pressure was less than 1 mmHg at each time point, but was statistically significant at weeks 1 and 4 (p< or =.047). At week 12, all subjects had noticed significant growth or darkening. Post hoc analysis of photographs corroborated these reports (p<.001).
Conclusion: Bimatoprost was found safe for eyelid application and was associated with enhanced eyelash growth. All subjects noticed favorable changes in the appearance of their eyelashes.
Comment in
-
Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.Dermatol Surg. 2010 May;36(5):650-1. doi: 10.1111/j.1524-4725.2010.01532.x. Epub 2010 Apr 1. Dermatol Surg. 2010. PMID: 20384740 Review. No abstract available.
Similar articles
-
Eyelash growth in subjects treated with bimatoprost: a multicenter, randomized, double-masked, vehicle-controlled, parallel-group study.J Am Acad Dermatol. 2012 May;66(5):801-6. doi: 10.1016/j.jaad.2011.06.005. Epub 2011 Sep 6. J Am Acad Dermatol. 2012. PMID: 21899919 Clinical Trial.
-
Commentary: From serendipity to pilot study and then pivotal trial: bimatoprost topical for eyelash growth.Dermatol Surg. 2010 May;36(5):650-1. doi: 10.1111/j.1524-4725.2010.01532.x. Epub 2010 Apr 1. Dermatol Surg. 2010. PMID: 20384740 Review. No abstract available.
-
Lack of efficacy of topical latanoprost and bimatoprost ophthalmic solutions in promoting eyelash growth in patients with alopecia areata.J Am Acad Dermatol. 2009 Apr;60(4):705-6. doi: 10.1016/j.jaad.2008.08.029. J Am Acad Dermatol. 2009. PMID: 19293023 Clinical Trial. No abstract available.
-
Bimatoprost 0.03% gel for cosmetic eyelash growth and enhancement.J Cosmet Dermatol. 2010 Jun;9(2):96-102. doi: 10.1111/j.1473-2165.2010.00487.x. J Cosmet Dermatol. 2010. PMID: 20618554 Clinical Trial.
-
Recovery of orbital fat pad prolapsus and deepening of the lid sulcus from topical bimatoprost therapy: 2 case reports and review of the literature.Cutan Ocul Toxicol. 2010 Sep;29(3):212-6. doi: 10.3109/15569521003796860. Cutan Ocul Toxicol. 2010. PMID: 20670089 Review.
Cited by
-
Ruxolitinib found to cause eyelash growth: a case report.J Med Case Rep. 2017 Jul 12;11(1):189. doi: 10.1186/s13256-017-1304-5. J Med Case Rep. 2017. PMID: 28701183 Free PMC article.
-
Advances in hair growth.Fac Rev. 2022 Jan 12;11:1. doi: 10.12703/r/11-1. eCollection 2022. Fac Rev. 2022. PMID: 35156098 Free PMC article. Review.
-
An Open-label, Single-center, Safety and Efficacy Study of Eyelash Polygrowth Factor Serum.J Clin Aesthet Dermatol. 2020 Feb;13(2):61-66. Epub 2020 Feb 1. J Clin Aesthet Dermatol. 2020. PMID: 32308787 Free PMC article.
-
From Eye Care to Hair Growth: Bimatoprost.Pharmaceuticals (Basel). 2024 Apr 27;17(5):561. doi: 10.3390/ph17050561. Pharmaceuticals (Basel). 2024. PMID: 38794131 Free PMC article. Review.
-
Comparative study of the efficacy and safety of topical minoxidil 2% versus topical bimatoprost 0.01% versus topical bimatoprost 0.03% in treatment of eyebrow hypotrichosis: a randomized controlled trial.Arch Dermatol Res. 2023 Nov;315(9):2635-2641. doi: 10.1007/s00403-023-02679-2. Epub 2023 Jul 30. Arch Dermatol Res. 2023. PMID: 37517060 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical